Showing results (641-650 of 928) with videos related to

Sort By:
Pageof 93
The Lancet. Diabetes & Endocrinology|July 24, 2018
Advances in the medical treatment of Cushing's syndromeRichard A Feelders, John Newell-Price, Rosario Pivonello, et al.
The Lancet. Diabetes & Endocrinology|July 31, 2018
Association of preoperative glucose concentration with myocardial injury and death after non-cardiac surgery (GlucoVISION): a prospective cohort studyZubin Punthakee, Pilar Paniagua Iglesias, Pablo Alonso-Coello, et al.
The Lancet. Diabetes & Endocrinology|July 19, 2018
Frailty and the endocrine systemAndrew Clegg, Zaki Hassan-Smith
The Lancet. Diabetes & Endocrinology|July 19, 2018
Clinical aspects of thyroid function during ageingLayal Chaker, Anne R Cappola, Simon P Mooijaart, et al.
The Lancet. Diabetes & Endocrinology|May 1, 2017
The global economic burden of diabetes in adults aged 20-79 years: a cost-of-illness studyChristian Bommer, Esther Heesemann, Vera Sagalova, et al.
The Lancet. Diabetes & Endocrinology|June 2, 2017
Relations between lipoprotein(a) concentrations, LPA genetic variants, and the risk of mortality in patients with established coronary heart disease: a molecular and genetic association studyStephen Zewinger, Marcus E Kleber, Vinicius Tragante, et al.
The Lancet. Diabetes & Endocrinology|February 6, 2015
Weight loss and incidence of diabetes with the Veterans Health Administration MOVE! lifestyle change programme: an observational studySandra L Jackson, Qi Long, Mary K Rhee, et al.
The Lancet. Diabetes & Endocrinology|February 10, 2015
Risk of all-cause mortality and vascular events in women versus men with type 1 diabetes: a systematic review and meta-analysisRachel R Huxley, Sanne A E Peters, Gita D Mishra, et al.
The Lancet. Diabetes & Endocrinology|February 10, 2015
Renal effects of atorvastatin and rosuvastatin in patients with diabetes who have progressive renal disease (PLANET I): a randomised clinical trialDick de Zeeuw, Deborah A Anzalone, Valerie A Cain, et al.
The Lancet. Diabetes & Endocrinology|March 6, 2023
Effects of dapagliflozin on hospitalisations in people with type 2 diabetes: post-hoc analyses of the DECLARE-TIMI 58 trialMeir Schechter, Stephen D Wiviott, Itamar Raz, et al.
Pageof 93